{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:39:29Z","timestamp":1791218369425,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection in children is most often mild and resembles that of seasonal coronaviruses. Profiling the adaptive immune response following infection may help to inform on the protective mechanisms mediating immunity in children and adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Humoral and cell-mediated immune responses from unvaccinated pediatric and adult participants were analyzed following non-Omicron SARS-CoV-2 infection. Specific T cell memory responses were investigated by quantifying interferon-gamma (IFN-\u03b3) secreting cells after stimulation with ancestral and variant strains of SARS-CoV-2 and seasonal human \u03b2-coronaviruses (HCoV)-OC43 and -HKU1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-eight children (3\u201317 [median\u2009=\u200910] years) and 28 adults (19\u201362 [median\u2009=\u200942] years) were sampled at a mean time of 7 months (\u00b12.8 months) after SARS-CoV-2 infection. Antibody levels against spike (S) and the receptor-binding domain (RBD), as well as neutralization capacity, were equivalent in adults and children. However, children displayed a lower number of IFN-\u03b3 secreting T cells in response to SARS-CoV-2 compared to adults, with a median of 88 [28\u2013184] spot-forming units (SFU) per million of cells in children compared to 208 [141\u2013340] in adults (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). In children, the IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      responses to SARS-CoV-2 were of similar magnitude as the responses to seasonal \u03b2-coronaviruses (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). In contrast, adults exhibited heightened T cell responses to SARS-CoV-2 than they did to HCoV-OC43 (median of 80 [45\u2013135] SFU\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and HCoV-HKU1 (median of 98 [59\u2013151] SFU\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In children, the functional T cell memory responses to SARS-CoV-2, assessed through IFN-\u03b3 secretion in response to peptide stimulation, are comparable to those of HCoVs and lower compared to adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>While binding and neutralizing antibody levels to SARS-CoV-2 are largely comparable in children and adults, the strength of memory T cell responses induced by infection is reduced in children compared to adults.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Adults present heightened cellular memory responses to SARS-CoV-2, but not to seasonal \u03b2-coronaviruses HCoV-OC43 and HCoV-HKU1.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>In contrast, children\u2019s T cell memory responses to SARS-CoV-2 closely mirror their response to common seasonal \u03b2-coronaviruses.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04256-x","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:19:36Z","timestamp":1755674376000},"page":"1104-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of adaptive immunity to SARS-CoV-2 in infected children and adults"],"prefix":"10.1038","volume":"99","author":[{"given":"Sabryna","family":"Nantel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maala","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eete","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Zemek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Decaluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5728-3134","authenticated-orcid":false,"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"4256_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1104518","volume":"11","author":"A Camporesi","year":"2023","unstructured":"Camporesi, A., Soares Lanziotti, V., Bulut, Y., Behrens, D. & Buonsenso, D. Editorial: Covid, long Covid, mental health, schools and masks: how and why we failed child health communication during a pandemic. Front. Pediatr. 11, 1104518 (2023).","journal-title":"Front. Pediatr."},{"key":"4256_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","volume":"174","author":"R Castagnoli","year":"2020","unstructured":"Castagnoli, R. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 174, 882\u2013889 (2020).","journal-title":"JAMA Pediatr."},{"key":"4256_CR3","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1093\/cid\/ciaa556","volume":"71","author":"NS Mehta","year":"2020","unstructured":"Mehta, N. S. et al. SARS-CoV-2 (COVID-19): what do we know about children? A systematic review. Clin. Infect. Dis. 71, 2469\u20132479 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"4256_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","volume":"27","author":"P Brodin","year":"2021","unstructured":"Brodin, P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 27, 28\u201333 (2021).","journal-title":"Nat. Med."},{"key":"4256_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1024924","volume":"13","author":"D Buonsenso","year":"2022","unstructured":"Buonsenso, D. et al. Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: a systematic review of clinical and immunological studies. Front. Immunol. 13, 1024924 (2022).","journal-title":"Front. Immunol."},{"key":"4256_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584, 430\u2013436 (2020).","journal-title":"Nature"},{"key":"4256_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41590-021-01123-9","volume":"23","author":"J Chou","year":"2022","unstructured":"Chou, J., Thomas, P. G. & Randolph, A. G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 23, 177\u2013185 (2022).","journal-title":"Nat. Immunol."},{"key":"4256_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","volume":"64","author":"JJ Zhang","year":"2023","unstructured":"Zhang, J. J., Dong, X., Liu, G. H. & Gao, Y. D. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin. Rev. Allergy Immunol. 64, 90\u2013107 (2023).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"4256_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25\u201331 (2021).","journal-title":"Nat. Immunol."},{"key":"4256_CR10","doi-asserted-by":"publisher","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang, H. S. et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw. Open 4, e214302 (2021).","journal-title":"JAMA Netw. Open"},{"key":"4256_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109773","volume":"37","author":"M Vono","year":"2021","unstructured":"Vono, M. et al. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Rep. 37, 109773 (2021).","journal-title":"Cell Rep."},{"key":"4256_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac554","volume":"9","author":"L Tomasi","year":"2022","unstructured":"Tomasi, L. et al. Younger children develop higher effector antibody responses to SARS-CoV-2 infection. Open Forum Infect. Dis. 9, ofac554 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"4256_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jpids\/piac012","volume":"11","author":"MS Han","year":"2022","unstructured":"Han, M. S. et al. Antibody responses to SARS-CoV-2 in children with COVID-19. J. Pediatr. Infect. Dis. Soc. 11, 267\u2013273 (2022).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"4256_CR14","doi-asserted-by":"publisher","unstructured":"Karron, R. A. et al. Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.157963 (2022).","DOI":"10.1172\/jci.insight.157963"},{"key":"4256_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jpids\/piad107","volume":"13","author":"M Kim","year":"2024","unstructured":"Kim, M. et al. Comparisons of pediatric and adult SARS-CoV-2-specific antibodies up to 6 months after infection, vaccination, or hybrid immunity. J. Pediatr. Infect. Dis. Soc. 13, 91\u201399 (2024).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"4256_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1046639","volume":"14","author":"LW Rumke","year":"2023","unstructured":"Rumke, L. W. et al. Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19. Front. Immunol. 14, 1046639 (2023).","journal-title":"Front. Immunol."},{"key":"4256_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"4256_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.904686","volume":"13","author":"E Moga","year":"2022","unstructured":"Moga, E., Lynton-Pons, E. & Domingo, P. The robustness of cellular immunity determines the fate of SARS-CoV-2 infection. Front. Immunol. 13, 904686 (2022).","journal-title":"Front. Immunol."},{"key":"4256_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","volume":"602","author":"M Yoshida","year":"2022","unstructured":"Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"4256_CR20","unstructured":"Public Health Agency of Canada. COVID-19 vaccination coverage in Canada. https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/ (2024)."},{"key":"4256_CR21","unstructured":"CDC. COVID-19 Vaccination Coverage and intent for Vaccination, Children 6 months through 17 years, United States. (2025) https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/covidvaxview\/interactive\/children-coverage-vaccination.html (2024)."},{"key":"4256_CR22","doi-asserted-by":"publisher","first-page":"E357","DOI":"10.9778\/cmajo.20220026","volume":"10","author":"M Bhatt","year":"2022","unstructured":"Bhatt, M. et al. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study. CMAJ Open 10, E357\u2013E366 (2022).","journal-title":"CMAJ Open"},{"key":"4256_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.930252","volume":"13","author":"S Nantel","year":"2022","unstructured":"Nantel, S. et al. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine. Front. Immunol. 13, 1\u201313 (2022).","journal-title":"Front. Immunol."},{"key":"4256_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/irv.12997","volume":"16","author":"\u00c9 Racine","year":"2022","unstructured":"Racine, \u00c9. et al. The REinfection in COVID-19 Estimation of Risk (RECOVER) study: reinfection and serology dynamics in a cohort of Canadian healthcare workers. Influenza Other Respir. Viruses 16, 916\u2013925 (2022).","journal-title":"Influenza Other Respir. Viruses"},{"key":"4256_CR25","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 Infection in Children: January 15, 2020 to June 30, 2021. Enhanced Epidemiological Summary (Queen\u2019s Printer for Ontario, 2021)."},{"key":"4256_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1380","volume":"11","author":"K Colwill","year":"2022","unstructured":"Colwill, K. et al. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin. Transl. Immunol. 11, e1380 (2022).","journal-title":"Clin. Transl. Immunol."},{"key":"4256_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10270","volume":"8","author":"F Cholette","year":"2022","unstructured":"Cholette, F. et al. Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens. Heliyon 8, e10270 (2022).","journal-title":"Heliyon"},{"key":"4256_CR28","doi-asserted-by":"publisher","unstructured":"Salem Fourati, I. et al. Development of an IFN-\u03b3 ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation. J. Vis. Exp. https:\/\/doi.org\/10.3791\/51643 (2014).","DOI":"10.3791\/51643"},{"key":"4256_CR29","doi-asserted-by":"publisher","unstructured":"Nantel, S. et al. Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity. Mucosal Immunol. https:\/\/doi.org\/10.1016\/j.mucimm.2024.01.004 (2024).","DOI":"10.1016\/j.mucimm.2024.01.004"},{"key":"4256_CR30","doi-asserted-by":"publisher","unstructured":"Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science https:\/\/doi.org\/10.1126\/science.abf4063 (2021).","DOI":"10.1126\/science.abf4063"},{"key":"4256_CR31","doi-asserted-by":"publisher","first-page":"828.e16","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828.e16\u2013842.e16 (2020).","journal-title":"Cell"},{"key":"4256_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84913-3","volume":"11","author":"MG Noval","year":"2021","unstructured":"Noval, M. G. et al. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities. Sci. Rep. 11, 5538 (2021).","journal-title":"Sci. Rep."},{"key":"4256_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"4256_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","volume":"41","author":"A Sette","year":"2023","unstructured":"Sette, A., Sidney, J. & Crotty, S. T cell responses to SARS-CoV-2. Annu. Rev. Immunol. 41, 343\u2013373 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"4256_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24938-4","volume":"12","author":"CA Cohen","year":"2021","unstructured":"Cohen, C. A. et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat. Commun. 12, 1\u201314 (2021).","journal-title":"Nat. Commun."},{"key":"4256_CR36","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1038\/s41467-022-35055-1","volume":"28","author":"E-M Jacobsen","year":"2022","unstructured":"Jacobsen, E.-M. et al. High antibody and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat. Commun. 28, 7315\u20137315 (2022).","journal-title":"Nat. Commun."},{"key":"4256_CR37","first-page":"1","volume":"13","author":"P Kaaijk","year":"2022","unstructured":"Kaaijk, P. et al. Children and adults with mild COVID-19: dynamics of the memory T cell response up to 10 months. Front. Immunol. 13, 1\u201315 (2022).","journal-title":"Front. Immunol."},{"key":"4256_CR38","doi-asserted-by":"publisher","unstructured":"Khoo, W. H. et al. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild\/asymptomatic COVID-19. Clin. Immunol. https:\/\/doi.org\/10.1016\/j.clim.2022.109209 (2023).","DOI":"10.1016\/j.clim.2022.109209"},{"key":"4256_CR39","doi-asserted-by":"publisher","unstructured":"Gentles, L. E. et al. Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.01.14.22269235 (2022).","DOI":"10.1101\/2022.01.14.22269235"},{"key":"4256_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell, A. C. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23, 40\u201349 (2022).","journal-title":"Nat. Immunol."},{"key":"4256_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100562","volume":"3","author":"K Kedzierska","year":"2022","unstructured":"Kedzierska, K. & Thomas, P. G. Count on us: T cells in SARS-CoV-2 infection and vaccination. Cell Rep. Med. 3, 100562 (2022).","journal-title":"Cell Rep. Med."},{"key":"4256_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"4256_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220320120","volume":"120","author":"M Humbert","year":"2023","unstructured":"Humbert, M. et al. Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age. Proc. Natl. Acad. Sci. USA 120, e2220320120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4256_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","volume":"361","author":"T Heikkinen","year":"2003","unstructured":"Heikkinen, T. & Jarvinen, A. The common cold. Lancet 361, 51\u201359 (2003).","journal-title":"Lancet"},{"key":"4256_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2022.1313","volume":"5","author":"ZQ Toh","year":"2022","unstructured":"Toh, Z. Q. et al. Comparison of seroconversion in children and adults with mild COVID-19. JAMA Netw. Open 5, 1\u201314 (2022).","journal-title":"JAMA Netw. Open"},{"key":"4256_CR46","doi-asserted-by":"publisher","first-page":"1489.e15","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489.e15\u20131501.e15 (2020).","journal-title":"Cell"},{"key":"4256_CR47","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/infdis\/jiab076","volume":"223","author":"KA Richards","year":"2021","unstructured":"Richards, K. A. et al. Circulating CD4 T cells elicited by endemic coronaviruses display vast disparities in abundance and functional potential linked to antigen specificity and age. J. Infect. Dis. 223, 1555\u20131563 (2021).","journal-title":"J. Infect. Dis."},{"key":"4256_CR48","doi-asserted-by":"publisher","unstructured":"Lokugamage, K. G. et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01410-20 (2020).","DOI":"10.1128\/JVI.01410-20"},{"key":"4256_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41587-021-01037-9","volume":"40","author":"J Loske","year":"2022","unstructured":"Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319\u2013324 (2022).","journal-title":"Nat. Biotechnol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04256-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:21:59Z","timestamp":1774527719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04256-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Boards at CHEO (CHEOREB#21\/08X) and the CR-CHUSJ (MP-21-2021-3035 and MP-21-2021-3046). Consent, and assent when indicated, were obtained from all participants and\/or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approvals"}}]}}